Nemaura Medical Inc. (NMRD)

Overview

Nemaura Medical Inc. is a pioneering medical technology company dedicated to the development and manufacturing of innovative glucose monitoring systems. Established in 2009 and headquartered in New York, New York, the company is committed to improving the lives of people with diabetes. Through advanced technology, Nemaura Medical Inc. focuses on providing non-invasive, pain-free glucose monitoring solutions. Its main objective is to support individuals with Type I and Type II diabetes in monitoring and managing their condition more effectively, whilst also offering products designed for pre-diabetic patients to prevent the onset of diabetes.

Products and Services

• sugarBEAT

  A flagship offering by Nemaura Medical Inc., sugarBEAT is a revolutionary continuous glucose monitoring (CGM) device. Designed to be non-invasive, sugarBEAT eliminates the need for painful finger-prick tests, making it an ideal glucose monitoring solution for persons with Type I and Type II diabetes. By adhering to the skin, this device provides real-time, actionable glucose readings that empower users to make informed decisions about their diet, exercise, and medication. sugarBEAT is also utilized for screening individuals who are pre-diabetic, thereby playing a critical role in diabetes prevention.

• proBEAT

  Building on the technology of sugarBEAT, proBEAT extends Nemaura Medical's offering into the wellness sector. This service provides wellness guidance notes, which include prompts and educational content to help users understand the various factors that affect their blood sugar levels. proBEAT is not just about monitoring; it's about educating and empowering users to take control of their health through better lifestyle choices. By doing so, it complements Nemaura’s efforts in diabetes prevention and reversal, making it a comprehensive tool for health and well-being.